Evidence is emerging that resveratrol (RV), a polyphenolic phytoaxelin present in dietary sources including red wine, may protect against atherosclerosis and cardiovascular disease by enhancing the integrity of the endothelium. In this study, the possibility that such beneficial effects of RV may arise from a modulation of protein kinase C (PKC)-mediated signaling was investigated by determining the effects of RV on the in vitro activities of PKC isozymes. It was found that the Ca 2 + -dependent activities of membrane-associated PKCa induced by either phorbol ester or diacylglycerol were potently inhibited by RV, each with an IC 50 of f 2 AM. The inhibitory effect of RV was also observed for conventional PKChI, whereas the activities of novel PKCq and atypical PKC~were each unaffected. The inhibition of PKCa activity was found to be competitive with respect to phorbol ester concentration but noncompetitive with respect to Ca 2 + and phosphatidylserine concentrations, suggesting that the RV may compete for phorbol ester-binding to the C1 domains. Supporting this, it was found that RV bound to a fusion peptide containing the C1A and C1B domains of PKCa. Similar to the effects of diacylglycerol and phorbol ester, the interaction of RV with the C1 domains induced the association of PKCa with membrane lipid vesicles, although this did not result in activation. Overall, the results suggest that the inhibitory effect of RV on PKC activity, and therefore on the associated signaling networks, may, in part, underlie the mechanism(s) by which this agent exerts its beneficial effects on endothelial and cardiovascular function. Furthermore, the effects of RV on these signaling networks are predicted to differ according to the cellular localization and the regulating PKC isozyme. D
Introduction
Coronary heart disease (CHD) remains the foremost cause of death in developed countries including the United States [1] . Common examples of vascular pathologies that are encompassed by CHD include myocardial infarction and angina pectoris, each of which results from a decrease in the diameter of heart vessel lumens due to the atherosclerotic deposition of fatty cholesterol-rich deposits. Atherosclerosis is therefore positively correlated with increased serum cholesterol levels, high blood pressure and high dietary saturated fat intake [2, 3] . However, a number of epidemiological studies have shown that some countries that have high dietary risk factors for CHD, in particular southern France, have a relatively decreased occurrence of this disease [4, 5] . Primary dietary factors that exert beneficial effects on cardiovascular function, in what has been termed the ''French Paradox,'' have been identified as certain polyphenolic components of red wine. In particular, 3,5,4V-trihydroxy-trans-stilbene, or resveratrol (RV), which is found in grape skins, has attracted considerable attention based on its observed cardioprotective effects [6 -18] .
The cellular mechanisms by which RV exerts an antiatherogenic and thus cardioprotective effects have been suggested to include the stimulation of endothelial vasorelaxation through stimulation of the NO-cGMP cascade [19] , the inhibition of LDL oxidation [20, 21] , inhibition of vascular NADH/NADPH oxidase [22] , and platelet aggregation and synthesis of eicosanoids [23 -25] . RV has been shown to inhibit the production of reactive oxygen species (ROS) in rat macrophages and human monocytes and granulocytes [26 -28] . Thus, RV is a potent scavenger of free radicals, which have been identified as a key factor in the production of oxidized LDL and in lipid peroxidation [29, 30] . RV also has anti-inflammatory properties [31, 32] , which are manifested as inhibition of ICAM-1 and VCAM-1 expression and the attachment of monocytes to endothelial cells, an inhibition of the lipopolysaccharide (LPS)-induced synthesis of TNF-a and IL-1-h, and a release of IL-6 from monocytes [33] . Elsewhere, it was shown that RV inhibits the generation of NO, the activation of NF-nB and the expression of iNOS [34] . In addition to effects on cytokine production, RV has also been shown to suppress the growth of endothelial cells, as well as cells derived from other tissues [31, 35, 36] . For example, the proliferation of bovine aortic endothelial cells was reported to be potently inhibited by RV-an effect that has been suggested to counteract atherogenic effects [35] .
Recent studies have indicated that the effects of RV on the processes of cytokine production, endothelial cell growth and proliferation, and also on changes in cell morphology, likely result from an impact on elements of the signaling networks that regulate them. In particular, it has been shown that RV can interfere with signaling cascades by modulating kinase and other enzyme activities. Thus, RV was shown to inhibit the proliferation of BPAEC cells and also to induce changes in morphology by a mechanism involving an impact on filamentous-actin (Factin) and microtubule assembly, intracellular calcium levels, and on tyrosine kinase activities [37] . Effects of RV on tyrosine phosphorylation have also been implicated in the inhibition of proliferation and the contraction of coronary artery smooth muscle induced by endothelin-1, which is an important mediator of cardiovascular disorders [38] . This effect appeared to be mediated by an inhibition of MAPK activity, phosphorylation and nuclear localization.
Evidence that protein kinase C (PKC)-mediated signaling, in particular, may be a target for RV has been presented in a recent study that showed that the stilbene blocked the phorbol ester-induced induction of COX-2 gene promoter activity mediated by AP-1 [39] . Consistent with this, another study showed that RV directly inhibited the activity of MAPK and, consequently, the phosphorylation of downstream kinases that lead to AP-1 activation [38] . Another recent study also provided evidence for an inhibition of AP-1 transcriptional activity mediated by the MAPK pathway, and showed that additional signaling molecules up-stream of Raf-1 or MEKK1, including PKC, may be targeted by RV [40] . The decreased production of COX-2 resulting from the inhibition of AP-1 was shown to coincide with an inhibition of the production of prostaglandin E 2 , which was suggested to provide a possible mechanism for the anti-inflammatory and cancer chemopreventative properties of RV [31] . In connection with the latter, RV has been shown to antagonize phorbol ester-induced tumor promotion in the mouse skin model, providing further evidence for an impact on PKC-mediated signaling [31] .
The minimal 12 isozymes that constitute the PKC family can be distinguished on the basis of the presence or absence of structural motifs that direct cofactor requirements for membrane-association and activation [41] . Thus, the ''conventional''-a, -hI, -hII and -g (cPKC) isozymes contain a conserved C1-domain that harbors the phorbol ester and diacylglycerol binding sites, and a C2-domain that binds two Ca 2 + -ions. The ''novel'' -y, -q, -D and -u (nPKC) isoforms contain a C1-domain but lack a functional C2-domain, which results in the membrane association and activation of these isoforms being Ca 2 + -independent. In the case of ''atypical'' PKC~and À L/E (aPKC), neither the C1 nor the C2 domains are functional and these isoforms are therefore unresponsive to Ca 2 + and phorbol esters or diacylglycerols. A general property of all of the PKC isozymes is that they each become active upon translocating to membranes containing anionic lipids such as phosphatidylserine [41] .
Support for the notion that RV effects on PKC-mediated signaling might involve a direct effect on PKC activity has been presented in a number of recent in vitro studies [42 -46] . However, whereas each study observed a weak inhibition of PKC activity by RV, the potency of the effect and the mechanism proposed for the effect appear to differ markedly according to the purity of the PKC isozyme preparations used and whether or not activators required for the optimal membrane association and activation of PKC were included in the assay systems employed. Therefore, the question whether an impact of RV on the activities of PKC isozymes and therefore on PKC mediated signaling networks might underlie some of the beneficial effects of the stilbene on cardiovascular function remains unresolved.
In this study, the mechanism of the effects of RV on the activities of purified recombinant PKC isozymes induced by association with model lipid vesicle membranes was investigated using an in vitro assay system in which the cofactorand activator-concentration dependencies for activation were systematically varied. It was found that RV inhibited membrane-associated PKCa activity within a concentration range relevant to the cellular effects of the stilbene [28,29,31,47 -49] . This effect was observed for conventional PKCa and PKChI, but not novel PKCq or atypical PKC~, and resulted from competition for activator binding to the C1 domains. The results support the contention that the beneficial effects of RV on endothelial cell function may, in part, be mediated by an impact on membrane-associated PKC activity and the associated signaling networks. 
Materials and methods

Expression and purification of PKC isozymes and C1 domains
Recombinant PKCa, -hI and -q (rat brain) were prepared using the baculovirus Spodoptera frugiperda (Sf9) insect cell expression system [50] and purified to homogeneity using published procedures [51, 52] . PKC~was overexpressed in Sf9 cells as fusion protein containing a (His) 6 attached to the C terminus, and a fusion protein corresponding to the C1A and C1B domains of PKCa (aC1A -C1B) was prepared as described previously [52, 53] . To provide structural stability, solubility, and to aid purification, the aC1A -C1B peptide was tagged with glutathione-S-transferase (GST) at the N terminus and with (His) 6 at the C terminus. The isolation and purification of the tagged protein was performed using previously described methods [52, 53] .
Measurements of PKC activity
PKC isozyme activities were assayed by measuring the rate of phosphate incorporation into a peptide substrate, as described previously [54] . For the ''conventional'' PKC isoforms, a peptide corresponding to the phosphorylation site domain of myelin basic protein [QKRPSQRSKYL, MBP 4 -14 ] was used as the substrate, whereas assays of ''novel'' PKC and ''atypical'' PKC~activity used a peptide corresponding to the pseudosubstrate region of ''novel'' PKCq (q-peptide), in which the single alanine residue was replaced by serine [55 -57] . Conventional PKC isozyme activities were measured using an assay (75 Al) consisting of 50 mM Tris/HCl (pH 7.40), POPC/BPS large unilamellar vesicles (LUV), CaCl 2 (0.1 mM), MBP 4 -14 (50 AM), TPA or DAG (0.3 and 4 mol% of the total lipid concentration, respectively, or as indicated), and RV at the indicated concentrations added from a 100 mM Me 2 SO stock. The maximum concentration of Me 2 SO in the assay systems used was 0.2% v/v, which was found in separate control experiments to have negligible effects on PKC isozyme activities. The activities of novel PKCq and atypical PKCw ere measured using an identical assay system, except that ethyleneglycol-bis-(h-aminoethyl ether)-N,N,NV ,NV -tetraacetic acid (EGTA) (0.1 mM) and peptide-q (50 AM) were substituted for CaCl 2 and MBP 4 -14 , respectively. The LUV, which were of diameter 100 nm, total lipid concentration 150 AM, and POPC/BPS molar ratio 4:1, unless stated otherwise, were prepared in a buffer consisting of 50 mM Tris/HCl (pH 7.40) and 0.1 mM EGTA as described previously [58] . In experiments where the level of BPS in LUV was varied or where DAG or TPA was added, each of these additions was done at the expense of POPC while keeping the total lipid concentration constant. The Ca 2 + -concentration dependencies of PKCa activity were determined by adding Ca 2 + as CaCl 2 at a level calculated to yield the required free level of Ca 2 + when buffered by 0.1 mM EGTA [59] . After thermal equilibration to 30 jC, assays were initiated by the simultaneous addition of the required PKC isoform (0.3 nM) along with 5 mM Mg 2 + , 100 AM ATP, 0.3 ACi [g 32 P] ATP (3000 Ci/mmol), and terminated after 30 min with 100 Al of 175 mM phosphoric acid. Following this, 100 Al was transferred to P81 filter papers, which were washed three times in 75 mM phosphoric acid. Phosphorylated peptide was determined by scintillation counting. The linearity of this assay system has been confirmed previously [54] .
Binding of RV to the C1 domains of PKCa
Fluorescence measurements were made at 30 jC using a SpectraMaxk Gemini plate reader (Molecular Devices, Inc., Sunnyvale, CA). The interaction of RV with the aC1A -C1B fusion peptide was determined by utilizing the apparent proportionality between the emission fluorescence intensity and the magnitude of a blue shift in the emission maximum of RV with the dielectric of its environment (i.e. hydrophobicity), as has been observed previously for the interaction of dansyl-lysine with membranes [60] . Initially, the excitation maximum of RV (1 AM) in water was estimated from the absorbance spectrum (not shown) to be 330 nm (molar extinction coefficient f 9000 M À 1 s À 1 ). The emission spectra of RV, obtained upon excitation at 330 nm, were then measured in a series of water -dioxane mixtures containing an increasing mole fraction of dioxane. Binding of RV to the aC1A -C1B domain was then measured from the corresponding increase in fluorescence intensity at the emission maximum of RV, as a function of RV concentration.
Interaction of PKCa with membranes
Determinations of the interaction of PKCa with membranes were performed based on surface plasmon resonance (SPR) measurements, using a BIAcorek 2000 (Biacore, Inc. Piscataway). The hydrophobic surface of a pioneer L1-chip (Biacore) was initially conditioned with a 15 Al injection of 50 mM CHAPS (5 Al/min). Following this, BPS/POPC LUV, prepared in an identical manner to those used in the activity assays (see above) except that the total lipid concentration was 500 AM and the buffer used contained 150 mM NaCl, were injected at a flow rate of 5 Al/ min. For experiments involving TPA, the phorbol ester was added to an aliquot of the 500 AM LUV to a level of 1.5 AM prior to injection so as to ensure that the mole fraction of TPA in the LUV captured on the L1-chip surface was identical to that used in the PKC activity assays (0.3 mol%). The resultant lipid surface was then conditioned by successive 15-Al injections of NaOH (10 mM) and glycine buffer (10 mM, pH 1.5). PKCa (5 nM) was then injected over the surface at a flow rate of 50 Al/min in a solution containing 50 mM Tris/HCl (pH 7.40), Mg 2 + (5 mM), ATP (100 AM), MBP 4 -14 (50 AM), with or without Ca 2 + (0.1 mM) and RV (50 AM), as indicated. The surface was regenerated by two successive 10-Al injections of 0.1% v/v Triton X-100. After subtraction of the contribution of bulk refractive index changes and nonspecific interactions of PKC isozymes with the L1-chip, which were typically less than 1% of the total signal, the individual association (k a ) and dissociation (k d ) rate constants were obtained by global fitting of data to a 1:1 Langmuir binding model using BIAevaluationk (Biacore). These values were then used to calculate the dissociation constant (K D ). The values of average squared residual (v 2 ) obtained were not significantly improved by fitting data to models that assumed bivalent or heterogeneous interactions. In a separate control experiment (results not shown), it was found that the contribution of mass transport to the observed values of K D was negligible, based on the observation that these values were independent of flow rate within a range encompassing that used (10 to 50 Al min À 1 ).
Results
In order to investigate the mechanism of the effects of RV on PKC isozyme activities, in vitro assays were utilized in which the levels of RV, phorbol ester, Ca 2 + and PS were systematically varied. PKC activities were determined using assays containing LUV of defined size and composition and peptide substrates, and have been shown previously to be free from aggregation, which might otherwise lead to complications in the interpretation of RV effects [54] .
Concentration-dependent effects of RV on PKC isozyme activities
The effects of RV on PKCa activity induced by PS and Ca 2 + alone, or with TPA or DAG, are shown in Fig. 1A . It was found that the ''basal'' activity of PKCa induced by Ca 2 + (0.1 mM) and PS (20 mol%) alone, which results from the partial membrane-association of the isozyme [61] , was inhibited by RV in a concentration dependent manner (Fig.  1A, inset) . However, under these conditions it was found that PKCa activity was only inhibited at relatively high RV concentrations and that this was not complete even at the highest levels of RV used (100 AM). By contrast, the activity of PKCa induced by Ca 2 + and PS in the presence of TPA (0.3 mol%) or DAG (4 mol%), under which condition the isozyme is fully membrane-associated [61] , was potently inhibited by RV with IC 50 values of 2.0 F 0.2 and 2.8 F 0.2 AM, respectively. Each of the dose -response curves fitted with least error to an equation that assumed the existence of a single binding site for RV. The inhibitory effect of RV was found to be relatively specific for PKCa (Fig. 1B) . Thus, whereas RV also inhibited the TPA-induced activity of membrane-associated PKChI, which is also classified as a conventional PKC isoform, the potency of this effect was reduced f 50-fold (IC 50 = 105 F 10 AM) compared to PKCa. Strikingly, the activities of both novel PKCq, induced by association with membranes containing TPA, and atypical PKC~, induced by membrane-association without TPA, were each unaffected by RV, even at levels in excess of 500 AM.
Effects of RV on the TPA-, PS-and Ca
2+ -concentration dependencies of PKCa activation
The results shown in Fig. 1A indicate that the potency of the inhibitory effects of RV on PKCa activity may differ depending on presence or absence of phorbol ester. The effect of increasing concentrations of RV (0, 1, 10, 50 AM) on the concentration dependence of TPA-induced PKCa activity, shown in Fig. 2A , was to shift the concentrationresponse curves to higher TPA levels, rather than to decrease the maximal level of activity attained. Thus, the presence of 1 AM RV resulted in a shift in the midpoint of the TPA-dose -response curve from 50 F 1.2 to 150 F 8 nM. These results suggest that the inhibitory effect of RV on membrane-associated PKCa activity may result from competition for TPA-binding to the isozyme.
The concentration -response curves for PKCa activation by Ca 2 + (Fig. 2B) and PS (Fig. 2C) , determined in the presence of a saturating level of TPA (0.3 mol%), were each found to be similar to those reported previously [61 -63] . By contrast to the effects of RV on the TPA-concentrationresponse curves, the presence of increasing levels of RV (0, 5, 50 AM) on the Ca 2 + -and PS-concentration-dependencies of membrane-associated PKCa activation resulted in a decrease in the maximal level of activity attained rather than a shift in the midpoint of the curve (Fig. 2B and C) . Thus, the inhibitory effect of RV appeared to be noncompetitive with respect to Ca 2 + -and PS-induced activation.
Interaction of RV with the C1 domains of PKCa
The above results suggest that the inhibitory effects of RV on TPA-induced PKCa activity may result from competition with the phorbol ester for binding to the activator binding sites within the C1 domains. In order to investigate this, the interaction of RV with a fusion protein containing the C1 domains of PKCa (aC1A -C1B) was determined by utilizing the apparent sensitivity of the fluorescence properties of RV to changes in the hydrophobicity of its environment. Thus, as shown in Fig. 3A , excitation of RV in water at 330 nm yielded an emission maximum (k max ) at 400 nm. Increasing the hydrophobicity of the RV solution by incrementally increasing the mole fraction of dioxane in a series of water -dioxane binary solvents resulted in a blue shift in k max and also to an increase in the fluorescence intensity at k max ( F max ). It was found that the value of k max for RV bound to the aC1A -C1B domain, obtained by subtraction of spectra obtained in the presence of the aC1A -C1B fusion peptide from that obtained in the presence of a peptide composed only of GST and His 6 , was again shifted to a shorter wavelength and that the value of F max was again increased compared to values obtained for RV in pure water (Fig. 3B) . The value of F max was found to increase as a function of the concentration of RV, whereas the value of k max remained constant. These results suggest that RV interacts with the hydrophobic activator binding sites within the aC1A -C1B domain. Consistent with this, as shown in Fig. 3B (inset) , the presence of increasing levels of TPA was found to result in a concentration-dependent decrease in the value of F max .
Effect of RV on PKCa binding to membranes
In order to investigate whether the inhibitory effect of RV on membrane-associated PKCa activity may have been due to an attenuation of the interaction of the isozyme with membranes, the effects of RV on membrane-association were determined using SPR (Fig. 4) . Results obtained in the absence of RV (Fig. 4A) indicated that a negligible level of membrane-association of PKCa occurred in the absence of both Ca 2 + and TPA (dashed line), as reported previously [61] . Also consistent with previous results [61, 64, 65] , the presence of TPA alone was found to result in a low level of binding of PKCa to the BPS/POPC LUV (dotted line), the affinity for which was markedly enhanced by the addition of Ca 2 + (solid line). This effect was found to correspond to a f 50-fold decrease in the value of K D , which corresponded primarily to an increase in k a , rather than a decrease in k d (Table 1) .
The presence of a fixed concentration of RV alone (50 AM) was found to induce the association of PKCa with BPS/POPC LUV (Fig. 4B) , as was found for TPA alone (Fig. 4A) . However, the affinity the interaction of PKCa with LUV induced by RV was found to be f 10-fold lower than that induced by TPA (Table 1) . Interestingly, similar to the synergistic effect of TPA in combination with Ca 2 + on PKCa binding to membranes, the presence of RV together with Ca 2 + was found to result in a f 30 fold decrease in the value of K D compared to that obtained for obtained for PKCa binding to LUV in the presence of RV alone (Table  1 ). However, the maximal level of RV-induced binding of PKCa to LUV was unaffected by the presence of Ca 2 + (Fig.  4B) . The level of PKCa binding to LUV induced by RV was similar to that induced by saturating levels of TPA and Ca 2 + , a condition that has been shown previously to be sufficient for the full membrane-association of this isozyme [61] . It was found that the value of K D obtained for PKCa binding to LUV in the presence of Ca . The maximal level of binding of PKCa to LUV induced by Ca 2 + , TPA and RV was again similar to that observed in the presence of Ca 2 + and TPA (compare Fig. 4A with Fig. 4B ).
Discussion
In this study, the mechanism of the effects of RV on the activities of PKC isozymes induced by association with membranes was investigated. It was found that the activities of conventional PKCa and PKChI, but not novel PKCq and atypical PKC~, were each potently inhibited by RV by a mechanism involving the displacement of phorbol ester-or DAG-binding to the C1 domains. The levels of RV required for this inhibitory effect were within a concentration-range encompassing those that have been shown previously to induce cellular effects that may underlie some of the cardioprotective properties of the stilbene [28,29,31,47 -49] .
A central aspect of the mechanism by which conventional PKC isozymes become active is their initial translocation to the membrane, which is mediated by two parallel , over LUV composed of BPS/POPC alone or containing 0.3 mol% TPA (solid line). The data were initially corrected for bulk shifts in response due to refractive index differences between buffers, and are representative of experiments carried out at least five times. Other details are given in Materials and methods. Table 1 Analysis of the effects of RV on the interaction of PKCa with BPS/POPC membranes using SPR but independent interactions [65] : The isozymes initially bind with low affinity to the membrane-surface through an interaction between the Ca 2 + -binding sites of the C2 domain and the head groups of anionic phospholipids, in particular PS. The affinity of membrane-association is then further increased by the insertion of the C1 domains into the membrane-interior, which is facilitated by DAG or phorbol ester binding. The combined interaction of the C1 and C2 domains with the membrane provides the energy to drive the conformational change that results in activation, which involves the folding out of the pseudosubstrate region from the active site [65] . The observed inhibitory effects of RV on conventional PKC activity may therefore potentially result either from an impact on the association of PKC with membranes or on the conformational change in the membrane-associated enzyme that results in activation.
The observation that RV both bound to a hydrophobic site within the aC1A -C1B peptide and competed with TPA for binding to this site suggests that the inhibition of PKC activity results from an interaction of RV with the C1 domains. This was also indicated by the observation that the inhibitory effect of RV on PKCa activity corresponded to a shift in the TPA dose -response curves for activation rather than a decrease in the maximal level of activity attained. Furthermore, the finding that the inhibitory effect of RV corresponded to a decrease in the amplitude, rather than a shift in the midpoint of the Ca 2 + -and PS-concentrationresponse curves, suggests that the initial interaction of PKCa with the membrane that is mediated by the C2 domain is unaffected by RV. The observation from SPR measurements that the presence of RV resulted in the recruitment of PKCa to LUV, and that Ca 2 + increased the affinity of this interaction, also indicates that the inhibitory effect of RV on PKCa activity does not result from an attenuated level of membrane-association. Indeed, the data suggest that the interaction of RV with the C1 domains may promote membrane-insertion by a similar mechanism to phorbol ester binding, which has been suggested to result from the capping of a hydrophilic base of the activator-binding site to form a contiguous hydrophobic surface [66] . However, the results also show that the interaction of RV with this site is not equivalent to that of phorbol esters or diacylglycerols in that it does not result in activation. Taken together, these observations imply that the energy derived from the penetration of the C1 domains into the membrane-interior, which is apparently induced by both phorbol ester and RV, is not sufficient to release the pseudosubstrate from the active site, and that this requires additional conformational changes in the C1 domains that are induced by phorbol ester but not RV. In connection with this, the results of a previous study from this laboratory indicated that phorbol ester binding to the C1 domain of PKCa results in a structural rearrangement in the domain which is involved in the overall conformational change in the PKC molecule that results in activation [67] .
The observation that the inhibitory effect of RV was confined to conventional PKCa and PKChI initially suggests that the inhibitory RV binding sites may not be present on the novel PKCq and atypical PKC~isozymes. Whereas PKC~lacks a functional activator-binding site within its single C1 domain [68] , and therefore may also be expected to lack a binding site for RV, this is not the case for PKCq, which is similar to PKCa in containing two C1 domains that bind activators. The differences in the effects of RV on PKCa and PKCq may therefore result from differing specificities of their C1 domains with respect to RV binding. Furthermore, the observation that the potency of the inhibition of PKChI activity by RV was f 50-fold less than for PKCa, even though the C1 domains of these isozymes share considerable homology, suggests that relatively subtle changes in C1 domain structure may have large effects on their specificities for RV binding. The interaction of phorbol esters with the binding pocket within the C1 domain has been shown previously to be mediated in part by hydrogen bonding [66,69 -71] . It is therefore possible that the hydroxyl moieties of RV may compete for these interactions resulting in the observed displacement of phorbol ester binding and inhibition of activity. Consistent with this, studies from this laboratory have shown that n-alkanols can also compete for phorbol ester binding to the C1 domains [72] .
Comparisons of the effects of RV on PKC isozyme activities observed in this study with those from previous work indicate that the potency of the inhibitory effects are markedly dependent on the conditions under which activation was induced [42 -46,73] . Thus, in a previous study it was observed that RV weakly inhibited the ''basal'' level of conventional PKC isozyme activity measured using an assay that contained PS and Ca 2 + but which excluded diacylglycerol or phorbol esters [43] , as was confirmed here ( Fig. 1,  inset ; EC 50 >100 AM). The level of RV required for an inhibitory effect under these conditions has been shown to be cytotoxic [74] , and also appears to be in large excess of that likely to be present in tissues after dietary intake [75 -78] . Therefore, it is unlikely that this sub-optimally activated form of PKC participates in the cellular effects of RV. However, it is shown here that inducing optimal association with PS containing membranes, and thus activation by including phorbol ester or diacylglycerol in the assay, results in a large increase in the inhibitory potency of RV (EC 50 f 2 AM). Consistent with this, it was shown previously [43] that PKC activity induced by interaction with the arginine-rich substrate, protamine sulfate, which circumvents the PS, Ca 2 + and activator requirements for optimal activation, was also potently inhibited by RV (EC 50 f 10 AM).
The mechanism of the inhibitory effect of RV may also differ according to the activating conditions used. Thus, a previous study showed that the observed weak inhibition of ''basal'' conventional PKC activity induced by PS and Ca 2 + alone involved competition for ATP binding, whereas the potent inhibition of optimal membrane-associated activity was found here to result from competition for activator binding to the C1 domains. Consistent with this, the previous study showed that the inhibition of optimal activity induced by protamine sulfate was noncompetitive with respect to ATP [43] . Interestingly, it was suggested that the inhibitory effect of RV on protamine sulfate activity involves an interaction with hydrophobic sites that are exposed upon activation which, based on the results of the present study, can be speculated to correspond to the C1 domains. The finding that the activities of PKCq and PKCw ere each unaffected by RV also argues against the possibility that the observed inhibitory effect of RV on optimal membrane-associated PKC activities may have involved competition for nucleotide binding, since the catalytic domains of these PKC isozymes share a high degree of structural homology.
Recently, it was reported that the autophosphorylation of PKC isozymes induced by PS, diacylglycerol and Ca 2 + was unaffected by RV, even though based on the present results these conditions would have been expected to induce optimal activation [44] . This apparent variation from the potent inhibitory effect observed here likely reflects differences in the levels of diacylglycerol and PS present in the assay systems used. Thus, whereas in the present study diacylglycerol was present at a level of 4 mol% in LUV containing 20 mol% PS, in the previous study it was incorporated at a fixed level of 24 mol% in vesicles that were composed purely of PS. Based on the observation of this study that the inhibition of PKC activity results from competition between RV and phorbol ester (or diacylglycerol) for binding to the C1 domains, such an increase in the level of diacylglycerol may account for the apparent decrease in the inhibitory potency of RV.
In conclusion, the levels of RV required to inhibit membrane-associated PKCa activity appear to be within a concentration range that is consistent with those reported to elicit cellular effects likely to be important in the physiological responses to the stilbene [28,29,31,47 -49] . In particular, by virtue of the centrality of PKC in signaling cascades that regulate the functioning of endothelial cells, the inhibitory effects of RV on PKC activities are likely to be important determinants in the mechanisms by which RV exerts its beneficial effects on cellular and cardiovascular function.
